280 related articles for article (PubMed ID: 15047237)
21. Sarcoma of the uterus. A clinical study of 42 patients.
Jereczek B; Jassem J; Kobierska A
Arch Gynecol Obstet; 1996; 258(4):171-80. PubMed ID: 8844134
[TBL] [Abstract][Full Text] [Related]
22. Cervical sarcomas: an analysis of incidence and outcome.
Wright JD; Rosenblum K; Huettner PC; Mutch DG; Rader JS; Powell MA; Gibb RK
Gynecol Oncol; 2005 Nov; 99(2):348-51. PubMed ID: 16051326
[TBL] [Abstract][Full Text] [Related]
23. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
Clarke MA; Devesa SS; Harvey SV; Wentzensen N
J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and surgical therapy of uterine sarcoma.
Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
26. Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.
Abel MK; Liao CI; Chan C; Lee D; Rohatgi A; Darcy KM; Tian C; Mann AK; Maxwell GL; Kapp DS; Chan JK
Gynecol Oncol; 2021 May; 161(2):470-476. PubMed ID: 33722415
[TBL] [Abstract][Full Text] [Related]
27. Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas?
Benito V; Lubrano A; León L; Molano F; Pinar B
Int J Gynecol Cancer; 2020 Nov; 30(11):1726-1732. PubMed ID: 32948637
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with survival differences between black women and white women with cancer of the uterine corpus.
Steinhorn SC; Myers MH; Hankey BF; Pelham VF
Am J Epidemiol; 1986 Jul; 124(1):85-93. PubMed ID: 3717143
[TBL] [Abstract][Full Text] [Related]
29. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract][Full Text] [Related]
30. Undiagnosed Uterine Sarcomas Identified During Surgery for Presumed Leiomyoma at a National Tertiary Hospital in Thailand: A 10-Year Review.
Ruengkhachorn I; Phithakwatchara N; Nawapun K; Hanamornroongruang S
Int J Gynecol Cancer; 2017 Jun; 27(5):973-978. PubMed ID: 28498251
[TBL] [Abstract][Full Text] [Related]
31. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM; Haggerty AF; Kim SH; Morgan MA; Giuntoli RL
Surg Oncol; 2021 Sep; 38():101589. PubMed ID: 33957499
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis, treatment and survival of uterine sarcoma: A retrospective cohort study of 122 cases.
Plentz TBSF; Candido EC; Dias LF; Toledo MCS; Vale DB; Teixeira JC
Mol Clin Oncol; 2020 Dec; 13(6):81. PubMed ID: 33093955
[TBL] [Abstract][Full Text] [Related]
33. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
Doll KM; Winn AN
Am J Obstet Gynecol; 2019 Oct; 221(4):318.e1-318.e9. PubMed ID: 31125544
[TBL] [Abstract][Full Text] [Related]
34. [Uterine sarcoma. Clinico-statistical study over 5 years (1963-1967)].
Cargnello U
Friuli Med; 1968; 23(6):997-1017. PubMed ID: 5738506
[No Abstract] [Full Text] [Related]
35. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
37. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
[TBL] [Abstract][Full Text] [Related]
39. Black race independently predicts worse survival in uterine carcinosarcoma.
Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
[TBL] [Abstract][Full Text] [Related]
40. Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study.
Gurumurthy M; Lahiri R; Scott N; Miller I; Cruickshank ME; Parkin DE
Scott Med J; 2013 May; 58(2):88-94. PubMed ID: 23728753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]